Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nordic Urothelial Cancer Research Group Study on Reduced BCG Dwell-Time in High Risk NMIBC

NCT04701151 is registered in ClinicalTrials.gov with Jørgen Bjerggaard Jensen as lead sponsor.

NCT NCT04701151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04701151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nordic Urothelial Cancer Research Group Study on Reduced BCG Dwell-Time in High Risk NMIBC
Lead sponsor
Jørgen Bjerggaard Jensen
Phase
Phase 4
Overall status
Active, not recruiting
Start date
February 3, 2021
Completion date
December 31, 2030
Enrollment
314 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

side effect of drug